Summit 2013 Sessions

FOR PATIENTS AND CAREGIVERS

Friday > Sessions

• Welcome and Introduction, Daniel M. Rose, MD, CEO and Chairman of the Board, Pulmonary Fibrosis Foundation | VIEW SLIDES  | WATCH WEBINAR

• Opening Session Keynote Address, Cystic Fibrosis Therapeutic Development: A Game Changer,  Robert J. Beall, PhD, President and CEO and Chairman of the Board, Cystic Fibrosis Foundation | VIEW SLIDES

• What is Pulmonary Fibrosis (PF), What are the Causes, and How is it Treated?, Harold R. Collard, MD  | VIEW SLIDES | WATCH WEBINAR

• What is Autoimmune Related Pulmonary Fibrosis?, Richard T. Meehan, MD  | VIEW SLIDES | WATCH WEBINAR

• What is Pulmonary Hypertension and How is it Related to PF?, Steven Kawut, MD, MS  | VIEW SLIDES | WATCH WEBINAR

• Special Luncheon Speaker: When Drug Research is Personal: The Importance of Patient Advocacy in Drug Development and Innovation, John F. Crowley, JD, MBA, Chairman and CEO, Amicus Therapeutics | VIEW SLIDES | VIEW WEBINAR

• Occupational and Environmental Related Pulmonary Fibrosis, Cecile S. Rose, MD, MPH  | VIEW SLIDES | WATCH WEBINAR

Saturday > Sessions

• Research Trials, Stem Cell Therapies, and the Drug Pipeline, Erica L. Herzog, MD  | VIEW SLIDES | WATCH WEBINAR

• Lung Transplantation and PF, Errol L. Bush, MD  | VIEW SLIDES | WATCH WEBINAR

• The Final Stages of Pulmonary Disease, Molly Bourne, MD  | VIEW SLIDES | WATCH WEBINAR

• Tools for Living Better with Pulmonary Fibrosis, Susan S. Jacobs, RN, MS  | VIEW SLIDES | WATCH WEBINAR

• Effective Advocacy for Pulmonary Fibrosis, Brian Baird, MS, PhD  | VIEW SLIDES | WATCH WEBINAR

• The Role of the FDA in the Process of Drug Development, Eugene J. Sullivan, MD  | VIEW SLIDES | WATCH WEBINAR

• US Food and Drug Administration -- Patient-Focused Drug Development Program, Richard M. Klein  | VIEW SLIDES | WATCH WEBINAR

• Meet the Experts–Q+A Roundtable Discussions

HOME  |  PULMONARY FIBROSIS FOUNDATION  |  FAQs  |  LEGAL TERMS AND CONDITIONS  | PRIVACY POLICY  |   CONTACT US